Home/Filings/4/0001078782-20-000704
4//SEC Filing

TERRELL JASON BRADLEY MD 4

Accession 0001078782-20-000704

CIK 0000093314other

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 5:21 PM ET

Size

8.5 KB

Accession

0001078782-20-000704

Insider Transaction Report

Form 4
Period: 2020-09-15
TERRELL JASON BRADLEY MD
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2020-09-15$3.23/sh19,500$62,98534,949 total
  • Exercise/Conversion

    Warrant (Right to Buy)

    2020-09-1825,0000 total
    Exercise: $2.47From: 2017-09-18Exp: 2020-09-18Common Stock (25,000 underlying)
  • Exercise/Conversion

    Common Stock

    2020-09-18$2.47/sh+25,000$61,75059,949 total
Footnotes (1)
  • [F1]On September 18, 2020, the Reporting Person exercised a warrant to purchase 25,000 shares of Common Stock of the issuer for $2.47 per share. The warrant was set to expire pursuant to its terms on September 18, 2020.

Issuer

VOLITIONRX LTD

CIK 0000093314

Entity typeother

Related Parties

1
  • filerCIK 0001567531

Filing Metadata

Form type
4
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 5:21 PM ET
Size
8.5 KB